v3.22.2.2
Balance Sheets - USD ($)
Sep. 30, 2022
Dec. 31, 2021
ASSETS    
Deferred offering costs $ 256,745 $ 126,422
Total Assets 256,745 126,422
Current Liabilities:    
Accrued formation costs 73,694 5,848
Due to related party 193,164 130,687
Total Current Liabilities 266,858 136,535
Commitments and contingencies  
Shareholders’ Deficit:    
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding
Ordinary shares, $0.0001 par value; 150,000,000 shares authorized; 1,725,000 shares issued and outstanding [1],[2] 173 173
Shareholder receivable (25,000) (25,000)
Additional paid-in capital 24,827 24,827
Accumulated deficit (10,113) (10,113)
Total Shareholders’ Deficit (10,113) (10,113)
Total Liabilities and Shareholders’ Deficit $ 256,745 $ 126,422
[1] Includes an aggregate of up to 225,000 founder shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters (see Note 7). On October 18, 2022, the underwriter partially exercised the over-allotment and as such, as of November 28, 2022, 150,000 ordinary shares are not subject to forfeiture.
[2] On December 20, 2021, the Company issued an additional 287,500 ordinary shares to the Sponsor for no additional consideration, resulting in the Sponsor holding an aggregate of 1,725,000 ordinary shares (the founder shares). The issuance was considered as a bonus share issuance, in substance a recapitalization transaction, which was recorded and presented retroactively. Each of the authorized but unissued 150,000,000 Class A ordinary shares were cancelled and re-designated as ordinary shares of $0.0001 par value each. Each of the 1,437,500 Class B ordinary shares in issue were exchanged in consideration for the issuance of 1,437,500 ordinary shares of $0.0001 par value each. Upon completion of the above steps, the authorized but unissued 10,000,000 Class B ordinary shares were cancelled.